Delivery Order SPE2DB22D2103-SPE2DB24FR8LG
- Not listed
- This federal contract award is a delivery order worth $31,927.34 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 60,000 unit capsules of the drug ZENPEP DR 100S, which is used for various medical conditions. The contract is a firm fixed-price agreement with a completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award from the Defense Logistics Agency (DLA) is a Firm Fixed Price Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,697.70 contract is for the supply of 40,000-unit capsules of the drug ZENPEP DR, with an ultimate completion date of November 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award, valued at $22,182.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 40,000 unit capsules of the drug ZENPEP, which is used to treat certain digestive disorders. The contract has an ultimate completion date of February 23, 2024 and is structured as a firm fixed price delivery order. It does not have a set-aside designation, indicating open competition....
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,364.06, is a delivery order for the supply of 40,000 units of the drug ZENPEP in 100-count capsule bottles. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $8,520.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 25,000 unit capsules of the drug ZENPEP DR 100S, which is used for various medical purposes. The contract is a Firm Fixed Price Delivery Order with a completion date of July 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.71 firm fixed-price delivery order covers the procurement of 4,564,544,240 units of the drug ZENPEP DR 20,000 in 100-count capsule containers. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award, valued at $6,190.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order for the supply of 15,000 units of the medication ZENPEP DR in 100-count capsule bottles. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $26,317.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,637,554 units of the drug Zenpep, a 40,000 unit capsule supplied in 100-count bottles. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,944.72 firm fixed-price delivery order is for the supply of 40,000 unit capsules of the drug ZENPEP, with a completion date of September 14, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8LGDelivery Order
This federal contract award, with ID SPE2DB22D2103|SPE2DB24FR8LG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40,000 unit capsules of the drug ZENPEP DR 100S, with a ceiling value of $26,895.46. It is a firm fixed-price delivery order contract with an ultimate completion date of October 26, 2023. The contract award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.9k | 10/25/23 |